Cell Death by SecTRAPs: Thioredoxin Reductase as a Prooxidant Killer of Cells
Open Access
- 2 April 2008
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 3 (4), e1846
- https://doi.org/10.1371/journal.pone.0001846
Abstract
SecTRAPs (selenium compromised thioredoxin reductase-derived apoptotic proteins) can be formed from the selenoprotein thioredoxin reductase (TrxR) by targeting of its selenocysteine (Sec) residue with electrophiles, or by its removal through C-terminal truncation. SecTRAPs are devoid of thioredoxin reductase activity but can induce rapid cell death in cultured cancer cell lines by a gain of function. Both human and rat SecTRAPs killed human A549 and HeLa cells. The cell death displayed both apoptotic and necrotic features. It did not require novel protein synthesis nor did it show extensive nuclear fragmentation, but it was attenuated by use of caspase inhibitors. The redox active disulfide/dithiol motif in the N-terminal domain of TrxR had to be maintained for manifestation of SecTRAP cytotoxicity. Stopped-flow kinetics showed that NADPH can reduce the FAD moiety in SecTRAPs at similar rates as in native TrxR and purified SecTRAPs could maintain NADPH oxidase activity, which was accelerated by low molecular weight substrates such as juglone. In a cellular context, SecTRAPs triggered extensive formation of reactive oxygen species (ROS) and consequently antioxidants could protect against the cell killing by SecTRAPs. We conclude that formation of SecTRAPs could contribute to the cytotoxicity seen upon exposure of cells to electrophilic agents targeting TrxR. SecTRAPs are prooxidant killers of cells, triggering mechanisms beyond those of a mere loss of thioredoxin reductase activity.Keywords
This publication has 79 references indexed in Scilit:
- Thioredoxin reductase-1 knock down does not result in thioredoxin-1 oxidationBiochemical and Biophysical Research Communications, 2008
- Targeting Thioredoxin Reductase 1 Reduction in Cancer Cells Inhibits Self-Sufficient Growth and DNA ReplicationPLOS ONE, 2007
- Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxideProceedings of the National Academy of Sciences, 2007
- Titration and Conditional Knockdown of the prfB Gene in Escherichia coli : Effects on Growth and Overproduction of the Recombinant Mammalian Selenoprotein Thioredoxin ReductaseApplied and Environmental Microbiology, 2007
- Mechanisms of Cell Death in Oxidative StressAntioxidants and Redox Signaling, 2007
- Caspase-2 Permeabilizes the Outer Mitochondrial Membrane and Disrupts the Binding of Cytochrome c to Anionic PhospholipidsJournal of Biological Chemistry, 2004
- A Small Molecule Smac Mimic Potentiates TRAIL- and TNFα-Mediated Cell DeathScience, 2004
- High-level expression in Escherichia coli of selenocysteine-containing rat thioredoxin reductase utilizing gene fusions with engineered bacterial-type SECIS elements and co-expression with the selA , selB and selC genes 1 1Edited by M. GottesmanJournal of Molecular Biology, 1999
- Efficient Reduction of Lipoamide and Lipoic Acid by Mammalian Thioredoxin ReductaseBiochemical and Biophysical Research Communications, 1996
- Two resident ER‐proteins, CaBP1 and CaBP2, with thioredoxin domains, are substrates for thioredoxin reductase: comparison with protein disulfide isomeraseFEBS Letters, 1995